TGTX
TGTX
NASDAQ · Biotechnology

Tg Therapeutics Inc

$31.82
+1.60 (+5.29%)
As of Mar 25, 9:55 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 12 80%
Hold 2 13%
Sell 1 7%
Price Target
Analyst Price Target +96.1% upside
Low Target $43.17
Average Target $62.39
High Target $72.87
Current Price $31.82
Current
$31.82
Target
$62.39
$43.17 $62.39 avg $72.87
Scenario Analysis
Bear Case
$43.17
35.7%
Low target
Base Case
$62.39
+96.1%
Avg target
Bull Case
$72.87
+129.0%
High target
Risk/Reward
3.6x
Highly favorable
Price in Context
52-Week High
$46.48
-31.5% from high
52-Week Low
$25.28
+25.9% from low
50-Day SMA
$30.02
+6.0% vs SMA
200-Day SMA
$32.89
-3.3% vs SMA
RSI (14)
46.3
Neutral
Target vs 52W High
$62.39
+34.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%